Allurion Technologies Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021
Cash & Equivalents	38.04	7.69	25.84
Cash & Cash Equivalents	38.04	7.69	25.84
Cash Growth	394.95%	-70.26%	-
Receivables	18.19	29.35	6.83
Inventory	6.17	3.87	2.72
Other Current Assets	2.41	2.49	1.94
Total Current Assets	64.82	43.38	37.33
Property, Plant & Equipment	6.39	5.28	1.71
Other Long-Term Assets	0.51	2.71	0.31
Total Long-Term Assets	6.9	7.99	2.03
Total Assets	71.71	51.37	39.35
Accounts Payable	10.38	5.81	1.62
Current Debt	39.55	54.27	24.14
Other Current Liabilities	15.5	15.79	5.85
Total Current Liabilities	65.43	75.87	31.61
Long-Term Debt	38.51	5.27	2
Other Long-Term Liabilities	38.27	2.55	0.9
Total Long-Term Liabilities	76.77	7.82	2.9
Total Liabilities	142.2	83.68	34.51
Total Debt	78.06	59.53	26.14
Debt Growth	31.12%	127.71%	-
Retained Earnings	-212.8	-132.19	-94.45
Comprehensive Income	-0.7	0	0
Shareholders' Equity	-70.49	-32.31	-34.29
Net Cash / Debt	-40.02	-51.85	-0.3
Net Cash Per Share	-1.12	-1.93	-0.04
Working Capital	-0.61	-32.48	5.72
Book Value Per Share	-1.98	-1.20	-4.84

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).